Arglabin | 9691

Arglabin is a potent anti-inflammatory and anticancer agent. It also acts as a Farnesyltransferase inhibitor and antiatherogenic compound. Prevents the accumulation of lipid containing plaques in arteries. In addition, Arglabin also acts as a NF-κB inhibitor and inflammasome inhibitor.

Arglabin is a potent anti-inflammatory and anticancer agent. It also acts as a Farnesyltransferase inhibitor and antiatherogenic compound. Prevents the accumulation of lipid containing plaques in arteries. In addition, Arglabin also acts as a NF-κB inhibitor and inflammasome inhibitor.

9691 | Arglabin DataSheet

Alternate Name/Synonyms: Arglabine

Appearance: White to off-white solid

Formulation: N/A

CAS Number: 84692-91-1

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₅H₁₈O₃

Molecular Weight: 246.3

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A potent anti-inflammatory, anticancer agent and fatnesyltransferase inhibitor

MDL Number: N/A

PubChem CID: 636760

SMILES: CC1=CCC23C1C4C(CCC2(O3)C)C(=C)C(=O)O4

InChi: InChI=1S/C15H18O3/c1-8-4-7-15-11(8)12-10(9(2)13(16)17-12)5-6-14(15,3)18-15/h4,10-12H,2,5-7H2,1,3H3/t10-,11-,12-,14-,15+/m0/s1

InChi Key: UVJYAKBJSGRTHA-ZCRGAIPPSA-N